Versatility of AAV vectors for retinal gene transfer

Vision Research

Volumn 48, Issue 3, 2008, Pages 353-359

  Surace, Enrico M ^a   Auricchio, Alberto ^a,b  

^a TELETHON INSTITUTE OF GENETICS AND MEDICINE TIGEM   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

AAV; Gene therapy; Retina

Indexed keywords

ANGIOGENESIS INHIBITOR; DOXYCYCLINE; ENHANCED GREEN FLUORESCENT PROTEIN; MUTANT PROTEIN; NEUROTROPHIC FACTOR; PARVOVIRUS VECTOR; PROTEIN RPGRIP; PROTEIN RS1H; RAPAMYCIN; TETRACYCLINE; UNCLASSIFIED DRUG; VIRUS VECTOR;

ARTICLE; CLINICAL TRIAL; DIABETIC RETINOPATHY; GENE MUTATION; GENE SEQUENCE; GENE TRANSFER; GENETIC TRANSDUCTION; GLAUCOMA; HUMAN; IN VIVO STUDY; LEBER CONGENITAL AMAUROSIS; NONHUMAN; OPTIC NEURITIS; PARVOVIRUS; PATHOGENESIS; PIGMENT EPITHELIUM; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; RETINA DISEASE; RETINA MACULA AGE RELATED DEGENERATION; RETINITIS PIGMENTOSA; RETROLENTAL FIBROPLASIA; SEROTYPE; SOMATIC GENE THERAPY; SUBRETINAL NEOVASCULARIZATION; TRANSCRIPTION REGULATION; TRANSGENE; VIRAL GENE THERAPY; VIRUS CAPSID; VIRUS GENOME; WILD TYPE;

ANIMALS; DEPENDOVIRUS; EYE DISEASES, HEREDITARY; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; RETINAL DISEASES; TRANSDUCTION, GENETIC;

EID: 38749087929     PISSN: 00426989     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.visres.2007.07.027     Document Type: Article

References (104)

1. Acland G.M., Aguirre G.D., Bennett J., Aleman T.S., Cideciyan A.V., Bennicelli J., et al. Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness. Molecular Therapy 12 6 (2005) 1072-1082
2. Acland G.M., Aguirre G.D., Ray J., Zhang Q., Aleman T.S., Cideciyan A.V., et al. Gene therapy restores vision in a canine model of childhood blindness. Nature Genetics 28 1 (2001) 92-95
3. Ali R.R., Reichel M.B., De Alwis M., Kanuga N., Kinnon C., Levinsky R.J., et al. Adeno-associated virus gene transfer to mouse retina. Human Gene Therapy 9 1 (1998) 81-86
4. Ali R.R., Reichel M.B., Thrasher A.J., Levinsky R.J., Kinnon C., Kanuga N., et al. Gene transfer into the mouse retina mediated by an adeno-associated viral vector. Human Molecular Genetics 5 5 (1996) 591-594
5. Ali R.R., Sarra G.M., Stephens C., Alwis M.D., Bainbridge J.W., Munro P.M., et al. Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy. Nature Genetics 25 3 (2000) 306-310
6. Allocca M., Tessitore A., Cotugno G., and Auricchio A. AAV-mediated gene transfer for retinal diseases. Expert Opinion on Biological Therapy 6 12 (2006) 1279-1294
7. Auricchio A. Pseudotyped AAV vectors for constitutive and regulated gene expression in the eye. Vision Research 43 8 (2003) 913-918
8. Auricchio A., Behling K., Maguire A., O'Connor E., Bennett L., Wilson J., et al. Inhibition of retinal neovascularization by intraocular viral-mediated delivery of anti-angiogenic agents. Molecular Therapy 6 4 (2002) 490
9. Auricchio A., Kobinger G., Anand V., Hildinger M., O'Connor E., Maguire A.M., et al. Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: The retina as a model. Human Molecular Genetics 10 26 (2001) 3075-3081
10. Auricchio A., O'Connor E., Weiner D., Gao G.P., Hildinger M., Wang L., et al. Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins. The Journal of Clinical Investigation 110 4 (2002) 499-504
11. Auricchio A., Rivera V., Clackson T., O'Connor E., Maguire A., Tolentino M., et al. Pharmacological regulation of protein expression from adeno-associated viral vectors in the eye. Molecular Therapy 6 2 (2002) 238
12. Auricchio A., and Rolling F. Adeno-associated viral vectors for retinal gene transfer and treatment of retinal diseases. Current Gene Therapy 5 3 (2005) 339-348
13. Bainbridge J.W., Mistry A., Binley K., De Alwis M., Thrasher A.J., Naylor S., et al. Hypoxia-regulated transgene expression in experimental retinal and choroidal neovascularization. Gene Therapy 10 12 (2003) 1049-1054
14. Bainbridge J.W., Mistry A., De Alwis M., Paleolog E., Baker A., Thrasher A.J., et al. Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1. Gene Therapy 9 5 (2002) 320-326
15. Bainbridge J.W., Tan M.H., and Ali R.R. Gene therapy progress and prospects: The eye. Gene Therapy 13 16 (2006) 1191-1197
16. Bennett J. Commentary: An aye for eye gene therapy. Human Gene Therapy 17 2 (2006) 177-179
17. Bennett J., Duan D., Engelhardt J.F., and Maguire A.M. Real-time, noninvasive in vivo assessment of adeno-associated virus- mediated retinal transduction. Investigative Ophthalmology & Visual Science 38 13 (1997) 2857-2863
18. Bennett J., and Maguire A.M. Gene therapy for ocular disease. Molecular Therapy 1 6 (2000) 501-505
19. Borras T., Brandt C.R., Nickells R., and Ritch R. Gene therapy for glaucoma: Treating a multifaceted, chronic disease. Investigative Ophthalmology & Visual Science 43 8 (2002) 2513-2518
20. Borras T., Xue W., Choi V.W., Bartlett J.S., Li G., Samulski R.J., et al. Mechanisms of AAV transduction in glaucoma-associated human trabecular meshwork cells. The Journal of Gene Medicine 8 5 (2006) 589-602
21. Burger C., Gorbatyuk O.S., Velardo M.J., Peden C.S., Williams P., Zolotukhin S., et al. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Molecular Therapy 10 2 (2004) 302-317
22. Campochiaro P.A. Gene therapy for ocular neovascularization. Current Gene Therapy 7 1 (2007) 25-33
23. Cearley C.N., and Wolfe J.H. Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain. Molecular Therapy 13 3 (2006) 528-537
24. Chao H., Liu Y., Rabinowitz J., Li C., Samulski R.J., and Walsh C.E. Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors. Molecular Therapy 2 6 (2000) 619-623
25. Chiorini J.A., Kim F., Yang L., and Kotin R.M. Cloning and characterization of adeno-associated virus type 5. Journal of Virology 73 2 (1999) 1309-1319
26. Chiorini J.A., Yang L., Liu Y., Safer B., and Kotin R.M. Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles. Journal of Virology 71 9 (1997) 6823-6833
27. Clackson T. Regulated gene expression systems. Gene Therapy 7 2 (2000) 120-125
28. Cremers F.P., van den Hurk J.A., and den Hollander A.I. Molecular genetics of Leber congenital amaurosis. Human Molecular Genetics 11 10 (2002) 1169-1176
29. Das A., and McGuire P.G. Retinal and choroidal angiogenesis: Pathophysiology and strategies for inhibition. Progress in Retinal and Eye Research 22 6 (2003) 721-748
30. Dejneka N.S., Auricchio A., Maguire A.M., Ye X., Gao G.P., Wilson J.M., et al. Pharmacologically regulated gene expression in the retina following transduction with viral vectors. Gene Therapy 8 6 (2001) 442-446
31. Dejneka N.S., Surace E.M., Aleman T.S., Cideciyan A.V., Lyubarsky A., Savchenko A., et al. In utero gene therapy rescues vision in a murine model of congenital blindness. Molecular Therapy 9 2 (2004) 182-188
32. Dinculescu A., Glushakova L., Min S.H., and Hauswirth W.W. Adeno-associated virus-vectored gene therapy for retinal disease. Human Gene Therapy 16 6 (2005) 649-663
33. Dryja T. Retinitis pigmentosa and stationary night blindness. In: Scriver C., Beaudet A., Sly W., and Valle D. (Eds). The metabolic & molecular bases of inherited diseases Vol. IV (2001), McGraw-Hill, New York, NY 5903-5933
34. Farrar G.J., Kenna P.F., and Humphries P. On the genetics of retinitis pigmentosa and on mutation-independent approaches to therapeutic intervention. The EMBO Journal 21 5 (2002) 857-864
35. Flannery J.G., Zolotukhin S., Vaquero M.I., LaVail M.M., Muzyczka N., and Hauswirth W.W. Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus. Proceedings of the National Academy of Sciences of the United States of America 94 13 (1997) 6916-6921
36. Folliot S., Briot D., Conrath H., Provost N., Cherel Y., Moullier P., et al. Sustained tetracycline-regulated transgene expression in vivo in rat retinal ganglion cells using a single type 2 adeno-associated viral vector. The Journal of Gene Medicine 5 6 (2003) 493-501
37. Gao G.P., Alvira M.R., Wang L., Calcedo R., Johnston J., and Wilson J.M. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proceedings of the National Academy of Sciences of the United States of America 99 18 (2002) 11854-11859
38. Gao G., Vandenberghe L.H., Alvira M.R., Lu Y., Calcedo R., Zhou X., et al. Clades of adeno-associated viruses are widely disseminated in human tissues. Journal of Virology 78 12 (2004) 6381-6388
39. Gao G., Vandenberghe L.H., and Wilson J.M. New recombinant serotypes of AAV vectors. Current Gene Therapy 5 3 (2005) 285-297
40. Glushakova L.G., Timmers A.M., Issa T.M., Cortez N.G., Pang J., Teusner J.T., et al. Does recombinant adeno-associated virus-vectored proximal region of mouse rhodopsin promoter support only rod-type specific expression in vivo?. Molecular Vision 12 (2006) 298-309
41. Gregorevic P., Blankinship M.J., Allen J.M., Crawford R.W., Meuse L., Miller D.G., et al. Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nature Medicine 10 8 (2004) 828-834
42. Guy J., Qi X., and Hauswirth W.W. Adeno-associated viral-mediated catalase expression suppresses optic neuritis in experimental allergic encephalomyelitis. Proceedings of the National Academy of Sciences of the United States of America 95 23 (1998) 13847-13852
43. Halbert C.L., Allen J.M., and Miller A.D. Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors. Journal of Virology 75 14 (2001) 6615-6624
44. Hennig A.K., Ogilvie J.M., Ohlemiller K.K., Timmers A.M., Hauswirth W.W., and Sands M.S. AAV-mediated intravitreal gene therapy reduces lysosomal storage in the retinal pigmented epithelium and improves retinal function in adult MPS VII mice. Molecular Therapy 10 1 (2004) 106-116
45. Hermonat P.L., and Muzyczka N. Use of adeno-associated vims as a mammalian DNA cloning vector: Transduction of neomycin resistance into mammalian tissue culture cells. Proceedings of the National Academy of Sciences of the United States of America 81 20 (1984) 6466-6470
46. Hildinger M., Auricchio A., Gao G., Wang L., Chirmule N., and Wilson J.M. Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer. Journal of Virology 75 13 (2001) 6199-6203
47. Ho T.T., Maguire A.M., Aguirre G.D., Surace E.M., Anand V., Zeng Y., et al. Phenotypic rescue after adeno-associated virus-mediated delivery of 4-sulfatase to the retinal pigment epithelium of feline mucopolysaccharidosis VI. The Journal of Gene Medicine 4 6 (2002) 613-621
48. Inagaki K., Fuess S., Storm T.A., Gibson G.A., McTiernan C.F., Kay M.A., et al. Robust systemic transduction with AAV9 vectors in mice: Efficient global cardiac gene transfer superior to that of AAV8. Molecular Therapy 14 1 (2006) 45-53
49. Jacobson S.G., Acland G.M., Aguirre G.D., Aleman T.S., Schwartz S.B., Cideciyan A.V., et al. Safety of recombinant adeno-associated virus type 2-RPE65 vector delivered by ocular subretinal injection. Molecular Therapy 31 6 (2006) 1074-1084
50. Jomary C., Vincent K.A., Grist J., Neal M.J., and Jones S.E. Rescue of photoreceptor function by AAV-mediated gene transfer in a mouse model of inherited retinal degeneration. Gene Therapy 4 7 (1997) 683-690
51. Kaplan J., Perrault R.J., and Unnich A. Leber congenital amaurosis. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D.M. (Eds). The metabolic and molecular bases of inherited disease Vol. 4 (2000), McGraw-Hill, New york, NY 5945-5947
52. Lai C.M., Shen W.Y., Brankov M., Lai Y.K., Barnett N.L., Lee S.Y., et al. Long-term evaluation of AAV-mediated sFlt-1 gene therapy for ocular neovascularization in mice and monkeys. Molecular Therapy 12 4 (2005) 659-668
53. Lai C.C., Wu W.C., Chen S.L., Xiao X., Tsai T.C., Huan S.J., et al. Suppression of choroidal neovascularization by adeno-associated virus vector expressing angiostatin. Investigative Ophthalmology & Visual Science 42 10 (2001) 2401-2407
54. Lebherz C., Auricchio A., Maguire A.M., Rivera V.M., Tang W., Grant R.L., et al. Long-term inducible gene expression in the eye via adeno-associated virus gene transfer in nonhuman primates. Human Gene Therapy 16 2 (2005) 178-186
55. LeMeur G., Stieger K., Smith A.J., Weber M., Deschamps J.Y., Nivard D., et al. Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium. Gene Therapy 14 4 (2007) 292-303
56. Liang F.Q., Aleman T.S., Dejneka N.S., Dudus L., Fisher K.J., Maguire A.M., et al. Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa. Molecular Therapy 4 5 (2001) 461-472
57. Limberis M.P., and Wilson J.M. Adeno-associated virus serotype 9 vectors transduce murine alveolar and nasal epithelia and can be readministered. Proceedings of the National Academy of Sciences of the United States of America 103 35 (2006) 12993-12998
58. Liu G., Martins I.H., Chiorini J.A., and Davidson B.L. Adeno-associated virus type 4 (AAV4) targets ependyma and astrocytes in the subventricular zone and RMS. Gene Therapy 12 20 (2005) 1503-1508
59. Lotery A.J., Yang G.S., Mullins R.F., Russell S.R., Schmidt M., Stone E.M., et al. Adeno-associated virus type 5: Transduction efficiency and cell-type specificity in the primate retina. Human Gene Therapy 14 17 (2003) 1663-1671
60. Martin K.R., Klein R.L., and Quigley H.A. Gene delivery to the eye using adeno-associated viral vectors. Methods 28 2 (2002) 267-275
61. Martin K.R., and Quigley H.A. Gene therapy for optic nerve disease. Eye 18 11 (2004) 1049-1055
62. Mastakov M.Y., Baer K., Kotin R.M., and During M.J. Recombinant adeno-associated virus serotypes 2- and 5-mediated gene transfer in the mammalian brain: Quantitative analysis of heparin co-infusion. Molecular Therapy 5 4 (2002) 371-380
63. McGee Sanftner L.H., Rendahl K.G., and Quiroz D. Recombinant AAV-mediated delivery of a tet-inducible reporter gene to the rat retina. Molecular Therapy 3 5 Pt 1 (2001) 688-696
64. McKinnon S.J., Lehman D.M., Tahzib N.G., Ransom N.L., Reitsamer H.A., Liston P., et al. Baculoviral IAP repeat-containing-4 protects optic nerve axons in a rat glaucoma model. Molecular Therapy 5 6 (2002) 780-787
65. Min S.H., Molday L.L., Seeliger M.W., Dinculescu A., Timmers A.M., Janssen A., et al. Prolonged recovery of retinal structure/function after gene therapy in an Rs1h-deficient mouse model of x-linked juvenile retinoschisis. Molecular Therapy 12 4 (2005) 644-651
66. Mori K., Gehlbach P., Yamamoto S., Duh E., Zack D.J., Li Q., et al. AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization. Investigative Ophthalmology & Visual Science 43 6 (2002) 1994-2000
67. Muzyczka N. Parvoviridae: The viruses and their replication. Fundamental virology (2001), Lippincott Williams & Wilkins, Philadelphia pp. 2327-2359
68. Narfstrom K., Katz M.L., Bragadottir R., Seeliger M., Boulanger A., Redmond T.M., et al. Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog. Investigative Ophthalmology & Visual Science 44 4 (2003) 1663-1672
69. Pacak C.A., Mah C.S., Thattaliyath B.D., Conlon T.J., Lewis M.A., Cloutier D.E., et al. Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo. Circulation Research 99 4 (2006) e3-e9
70. Pang J.J., Chang B., Kumar A., Nusinowitz S., Noorwez S.M., Li J., et al. Gene therapy restores vision-dependent behavior as well as retinal structure and function in a mouse model of RPE65 Leber congenital amaurosis. Molecular Therapy 13 3 (2006) 565-572
71. Passini M.A., Watson D.J., Vite C.H., Landsburg D.J., Feigenbaum A.L., and Wolfe J.H. Intraventricular brain injection of adeno-associated virus type 1 (AAV1) in neonatal mice results in complementary patterns of neuronal transduction to AAV2 and total long-term correction of storage lesions in the brains of beta-glucuronidase-deficient mice. Journal of Virology 77 12 (2003) 7034-7040
72. Pawlyk B.S., Smith A.J., Buch P.K., Adamian M., Hong D.H., Sandberg M.A., et al. Gene replacement therapy rescues photoreceptor degeneration in a murine model of Leber congenital amaurosis lacking RPGRIP. Investigative Ophthalmology & Visual Science 46 9 (2005) 3039-3045
73. Pollock R., Issner R., Zoller K., Natesan S., Rivera V.M., and Clackson T. Delivery of a stringent dimerizer-regulated gene expression system in a single retroviral vector. Proceedings of the National Academy of Sciences of the United States of America 97 24 (2000) 13221-13226
74. Qi X., Hauswirth W.W., and Guy J. Dual gene therapy with extracellular superoxide dismutase and catalase attenuates experimental optic neuritis. Molecular Vision 13 (2007) 1-11
75. Rabinowitz J.E., Rolling F., Li C., Conrath H., Xiao W., Xiao X., et al. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. Journal of Virology 76 2 (2002) 791-801
76. Rabinowitz J.E., and Samulski RJ. Building a better vector: The manipulation of AAV virions. Virology 278 2 (2000) 301-308
77. Rabinowitz J.E., and Samulski R.J. The adeno-associated virus crystal: Impact inversely proportional to size. Molecular Therapy 6 4 (2002) 443-445
78. Raisler B.J., Berns K.I., Grant M.B., Beliaev D., and Hauswirth W.W. Adeno-associated virus type-2 expression of pigmented epithelium-derived factor or Kringles 1-3 of angiostatin reduce retinal neovascularization. Proceedings of the National Academy of Sciences of the United States of America 99 13 (2002) 8909-8914
79. Renwick J., Narang M.A., Coupland S.G., Xuan J.Y., Baker A.N., Brousseau J., et al. XIAP-mediated neuroprotection in retinal ischemia. Gene Therapy 13 4 (2006) 339-347
80. Rivera V.M., Clackson T., Natesan S., Pollock R., Amara J.F., Keenan T., et al. A humanized system for pharmacologic control of gene expression. Nature Medicine 2 9 (1996) 1028-1032
81. Rolling F., Shen W.Y., Barnett N.L., Tabarias H., Kanagasingam Y., Constable I., et al. Long-term real-time monitoring of adeno-associated virus-mediated gene expression in the rat retina. Clinical and Experimental Ophthalmology 28 5 (2000) 382-386
82. Rolling F., Shen W.Y., Tabarias H., Constable I., Kanagasingam Y., Barry C.J., et al. Evaluation of adeno-associated virus-mediated gene transfer into the rat retina by clinical fluorescence photography. Human Gene Therapy 10 4 (1999) 641-648
83. Rutledge E.A., Halbert C.L., and Russell D.W. Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. Journal of Virology 72 1 (1998) 309-319
84. Sarra G.M., Stephens C., de Alwis M., Bainbridge J.W., Smith A.J., Thrasher A.J., et al. Gene replacement therapy in the retinal degeneration slow (rds) mouse: The effect on retinal degeneration following partial transduction of the retina. Human Molecular Genetics 10 21 (2001) 2353-2361
85. Sarra G.M., Stephens C., Schlichtenbrede F.C., Bainbridge J.W., Thrasher A.J., Luthert P.J., et al. Kinetics of transgene expression in mouse retina following sub-retinal injection of recombinant adeno-associated virus. Vision Research 42 4 (2002) 541-549
86. Schlichtenbrede F.C., da Cruz L., Stephens C., Smith A.J., Georgiadis A., Thrasher A.J., et al. Long-term evaluation of retinal function in Prph2Rd2/Rd2 mice following AAV-mediated gene replacement therapy. The Journal of Gene Medicine 5 9 (2003) 757-764
87. Sheffield V.C.W., and Alward L.M. The glaucomas. The metabolic and molecular bases of inherited disease Vol. IV (2000), McGraw-Hill, New York, St. Louis, San Francisco 6063-6093
88. Smith A.J., Schlichtenbrede F.C., Tschernutter M., Bainbridge J.W., Thrasher A.J., and Ali R.R. AAV-mediated gene transfer slows photoreceptor loss in the RCS rat model of retinitis pigmentosa. Molecular Therapy 8 2 (2003) 188-195
89. Smith J.R., Verwaerde C., Rolling F., Naud M.C., Delanoye A., Thillaye-Goldenberg B., et al. Tetracycline-inducible viral interleukin-10 intraocular gene transfer, using adeno-associated virus in experimental autoimmune uveoretinitis. Human Gene Therapy 16 9 (2005) 1037-1046
90. Stieger K., Le Meur G., Lasne F., Weber M., Deschamps J.Y., Nivard D., et al. Long-term doxycycline-regulated transgene expression in the retina of nonhuman primates following subretinal injection of recombinant AAV vectors. Molecular Therapy 13 5 (2006) 967-975
91. Surace E.M., and Auricchio A. Adeno-associated viral vectors for retinal gene transfer. Progress in Retinal and Eye Research 22 6 (2003) 705-719
92. Surace E.M., Auricchio A., Reich S.J., Rex T., Glover E., Pineles S., et al. Delivery of adeno-associated virus vectors to the fetal retina: Impact of viral capsid proteins on retinal neuronal progenitor transduction. Journal of Virology 77 14 (2003) 7957-7963
93. Surace E.M., Domenici L., Cortese K., Cotugno G., Di Vicino U., Venturi C., et al. Amelioration of both functional and morphological abnormalities in the retina of a mouse model of ocular albinism following AAV-mediated gene transfer. Molecular Therapy 12 4 (2005) 652-658
94. Tratschin J.D., West M.H., Sandbank T., and Carter BJ. A human parvovirus, adeno-associated virus, as a eucaryotic vector: Transient expression and encapsidation of the procaryotic gene for chloramphenicol acetyltransferase. Molecular and Cellular Biology 4 10 (1984) 2072-2081
95. Tuo J., Bojanowski CM., and Chan C.C. Genetic factors of age-related macular degeneration. Progress in Retinal and Eye Research 23 2 (2004) 229-249
96. Vetrini F., Auricchio A., Du J., Angeletti B., Fisher D.E., Ballabio A., et al. The microphthalmia transcription factor (Mitf) controls expression of the ocular albinism type 1 gene: Link between melanin synthesis and melanosome biogenesis. Molecular and Cellular Biology 24 15 (2004) 6550-6559
97. Wang Z., Zhu T., Qiao C., Zhou L., Wang B., Zhang J., et al. Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nature Biotechnology 23 3 (2005) 321-328
98. Weber M., Rabinowitz J., Provost N., Conrath H., Folliot S., Briot D., et al. Recombinant adeno-associated virus serotype 4 mediates unique and exclusive long-term transduction of retinal pigmented epithelium in rat, dog, and nonhuman primate after subretinal delivery. Molecular Therapy 7 6 (2003) 774-781
99. Wilson J.H., and Wensel T.G. The nature of dominant mutations of rhodopsin and implications for gene therapy. Molecular Neurobiology 28 2 (2003) 149-158
100. Xiao W., Chirmule N., Berta S.C., McCullough B., Gao G., and Wilson J.M. Gene therapy vectors based on adeno-associated virus type 1. Journal of Virology 73 5 (1999) 3994-4003
101. Yang G.S., Schmidt M., Yan Z., Lindbloom J.D., Harding T.C., Donahue B.A., et al. Virus-mediated transduction of murine retina with adeno-associated virus: Effects of viral capsid and genome size. Journal of Virology 76 15 (2002) 7651-7660
102. Zabner J., Seiler M., Walters R., Kotin R.M., Fulgeras W., Davidson B.L., et al. Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer. Journal of Virology 74 8 (2000) 3852-3858
103. Zeng Y., Takada Y., Kjellstrom S., Hiriyanna K., Tanikawa A., Wawrousek E., et al. RS-1 gene delivery to an adult Rslh knockout mouse model restores ERG b-wave with reversal of the electronegative waveform of X-linked retinoschisis. Investigative Ophthalmology & Visual Science 45 9 (2004) 3279-3285
104. Zhou Y., Pernet V., Hauswirth W.W., and Di Polo A. Activation of the extracellular signal-regulated kinase 1/2 pathway by AAV gene transfer protects retinal ganglion cells in glaucoma. Molecular Therapy 12 3 (2005) 402-412